Physician

Patricia M. O'Hare, M.D.

According to 2025 Medicare claims, Patricia O'Hare, M.D. (NPI: 1821030693) practices dermatology in the Albany, OR market, with the plurality of this provider's patient population coming from Linn, OR. This provider's primary affiliated billing organization is BRUNE DERMATOLOGY, LLC (NPI: 1093037210; TIN: 27-1724597) and primary practice location at 97322-6661.

O'Hare's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 895 traditional Medicare patients, billed 2,575 HCPCS/CPT codes, and received $97,084 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 742 prescription claims across 304 beneficiaries totaling $953,459 in drug costs, led by Dupixent Pen (Dupilumab). Open Payments data shows 5 records totaling $197. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $118,276 to $97,084. In contrast, Part D prescription costs have risen steadily, from $59,275 to $953,459. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$70K$141K2015 Medicare payment: $118,276 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $136,553 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $132,189 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $132,637 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $140,829 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $107,170 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $124,464 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $93,119 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $83,767 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $97,084 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20156562,707$118,276
20168073,292$136,553
20178443,566$132,189
20188833,501$132,637
20199723,425$140,829
20208702,494$107,170
20219683,241$124,464
20228012,406$93,119
20236941,944$83,767
20248952,575$97,084

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$613K$1.2M2015 Drug cost: $59,275 (USD; Tot_Drug_Cst)2016 Drug cost: $163,839 (USD; Tot_Drug_Cst)2017 Drug cost: $441,566 (USD; Tot_Drug_Cst)2018 Drug cost: $562,510 (USD; Tot_Drug_Cst)2019 Drug cost: $811,709 (USD; Tot_Drug_Cst)2020 Drug cost: $1,063,248 (USD; Tot_Drug_Cst)2021 Drug cost: $1,089,544 (USD; Tot_Drug_Cst)2022 Drug cost: $1,225,987 (USD; Tot_Drug_Cst)2023 Drug cost: $622,845 (USD; Tot_Drug_Cst)2024 Drug cost: $953,459 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015238609$59,275
2016345784$163,839
2017346845$441,566
2018338895$562,510
20194011,084$811,709
20203751,070$1,063,248
20214251,152$1,089,544
2022345991$1,225,987
2023239512$622,845
2024304742$953,459

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
17110Destruction of skin growth, 1-14 growths219248$68
99203New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more200200$51
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more636750$49
17000Destruction of precancer skin growth, 1 growth289313$32
17003Destruction of precancer skin growth, 2-14 growths185703$4

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Dupixent PenDupilumab341,064$158,910
Cosentyx Sensoready (2 Pens)Secukinumab17476$145,641
Humira(Cf)Adalimumab13364$115,099
AdbryTralokinumab-Ldrm13364$50,634
FluorouracilFluorouracil391,264$2,442

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.5$197PFIZER INC.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Patricia M. O'Hare, M.D.?

Tedicare shows public-source Medicare data for Patricia M. O'Hare, M.D. (NPI 1821030693), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Patricia M. O'Hare, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Patricia M. O'Hare, M.D.?

Patricia M. O'Hare, M.D. is linked to BRUNE DERMATOLOGY, LLC (billing NPI 1093037210) in the available physician profile data.

Does Patricia M. O'Hare, M.D. have Open Payments data?

Patricia M. O'Hare, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.